期刊文献+

核型分析和染色体微阵列技术在超声软指标异常胎儿产前诊断中的应用 被引量:1

Application of karyotyping and chromosome microarray analysis in prenatal diagnosis of fetuses with abnormal ultrasonographic soft markers
原文传递
导出
摘要 目的 探讨核型分析和染色体微阵列技术(CMA)在超声软指标异常胎儿产前诊断中的应用。方法 选取同时行核型分析和CMA检测的345例中孕期软指标异常但无明确结构畸形的单胎孕妇,对检测结果和孕妇资料进行分析。结果 345例孕妇软指标异常的病例中,孤立单项软指标152例,合并其他产前指征149例,两项及以上软指标44例,致病性染色体异常检出率分别为2.63%(4/152)、10.74%(16/149)、20.45%(9/44),3组检出率差异有统计学意义(χ^(2)=15.932,P<0.001)。不同软指标的致病性染色体异常检出率为0.00%~21.43%,颈背部皮肤皱褶(NF)增厚最高(21.43%),其次是鼻骨缺失/发育不良(12.68%)。345例病例中,核型分析染色体异常检出率为7.25%(25/345),CMA检出率为14.49%(50/345);4例核型异常CMA未检出异常;CMA在核型正常病例中检出29例基因组拷贝数变异(CNV)。结论 NF增厚、鼻骨缺失/发育不良、两项及以上软指标异常或软指标合并其他产前指征胎儿有较高的致病性染色体异常检出率,建议行介入性产前诊断;核型分析和CMA的检测结果可以互相验证补充,两者结合可提供更加准确和有效的遗传学诊断。 Objective To explore the clinical application value of karyotyping and chromosome microarray analysis( CMA)in prenatal diagnosis of fetuses with abnormal ultrasonographic soft markers( USM).Methods A total of 345 singleton pregnant women with abnormal USM but without structural abnormalities who had both karyotyping and CMA testing were selected. Then, the test results and maternal data were analyzed.Results Among the 345 cases of abnormal USM, there were 152 cases with single USM, 149 cases with other prenatal diagnosis indications, and 44 cases with multiple USM. The detection rates of pathogenic chromosomal abnormalities were 2. 63%(4/152), 10. 74%( 16/149) and 20. 45%( 9/44),respectively. The difference in detection rates between the three groups was statistically significant(χ^(2) = 15. 932,P<0. 001). The detection rate of pathogenic chromosomal abnormalities with different USM ranged from 0. 00% to 21. 43%.The USM with the highest detection rate of pathogenic chromosomal abnormalities was nuchal fold( NF) thickening(21. 43%), followed by nasal bone loss/dysplasia( 12. 68%). In the 345 cases, the detection rate of karyotyping chromosomal abnormalities was 7. 27%(25/345), and the detection rate of CMA was 14. 53%(50/345). No abnormality was detected by CMA in 4 fetuses with chromosomal abnormality by karyotyping. Among cases with normal karyotypes, 29 copy number variation( CNV) were detected by CMA.Conclusion The fetus with NF thickening, nasal bone loss/dysplasia,multiple USM abnormalities or single USM abnormality combined with other prenatal indications have a higher detection rate of pathogenic chromosomal abnormality. Therefore, it is recommended to conduct interventional prenatal diagnosis. The results of karyotyping and CMA can be mutually verified and supplemented to provide a more accurate and effective genetic diagnosis for fetuses with abnormal USM.
作者 涂华玉 黄道奇 唐俊湘 王朝红 李景然 朱健生 TU Hua-yu;HUANG Dao-qi;TANG Jun-xiang;WANG Chao-hong;LI Jing-ran;ZHU Jian-sheng(Center for Genetic Medicine,Anhui Maternal and Child Health Care Hospital Affiliated to Anhui Medical University,Hefei 230001,Anhui,China)
出处 《安徽预防医学杂志》 2022年第5期376-379,共4页 Anhui Journal of Preventive Medicine
基金 安徽省重点研究与开发计划项目(202004j07020004) 安徽医科大学青年科学基金(2021xkj110)。
关键词 超声软指标 产前诊断 染色体微阵列技术 核型分析 优生优育 Ultrasonographic soft marker Prenatal diagnosis Chromosome microarray analysis Karyotyping prenatal and postnatal care
  • 相关文献

参考文献3

二级参考文献26

  • 1Brady PD, Vermeesch JR. Genomic microarrays: a technology overview[J]. Prenat Diagn, 2012,32:336-343. 被引量:1
  • 2Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. Am J Hum Genet, 2010,86: 749-764. 被引量:1
  • 3Hillman SC, McMullan DJ, Hall G, et al. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol, 2013,41:610-620. 被引量:1
  • 4Shaffer LG, Dabell MP, Fisher AJ, et al. Experience with microarray-based comparative genomie hybridization for prental diagnosis in over 5000 pregnancies[J]. Prenat Diagn, 2012,32: 976-985. 被引量:1
  • 5Shaffer LG, Dosenfeld JA, Dabell MP, et al. Detection rates of clinically significant genomie alterations by mieroarray analysis for specific anomalies detected by ultrasound[J]. Prenat Diagn, 2012,32:986-995. 被引量:1
  • 6Wapner R J, Marthin CL, Lery B, et al. Chromosomal microarray versus karyotyping for prental diagnosis[J]. N Engl J Med, 2012, 367:2175-2184. 被引量:1
  • 7American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis[J]. Obstet Gynecol,2013,122:1374-1377. 被引量:1
  • 8Ma J, Cram DS, Zhang J, et al. Birth of a child with trisomy 9 mosaicism syndrome associated with paternal isodisomy 9 : case of a positive noninvasive prenatal test result unconfirmed by invasive prenatal diagnosis[ J]. Mol Cytogenet, 2015,6 (26) :8-44. 被引量:1
  • 9Ma J, Hong P, Fu J, et al. Prenatal diagnostic testing among women referred for advanced maternal age in Beijing, 2001-2012 [ J]. Int J Gynaecol Obstet, 2014,125 ( 3 ) : 232-236. DOI: 10.1016/j. ijgo. 2013.12. 004. 被引量:1
  • 10Shaffer LG, McGowan-Jordan J, Schmid M. ISCN 2013: An International System for Human Cytogenetic Nomenclature (2013) [M]. Nomenclature, Basel:S. Karger AG, 2013. 被引量:1

共引文献253

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部